TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34458922

Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam therapy
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Renal replacement therapy on the day of reoperation
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Renal replacement therapy on reoperation
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Peritoneal cultures containing Klebsiella spp.
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Pancreatic source of infection
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Microbiological failure
Number of subjects: 236
Study: 33547717

Group type: EXPERIMENTAL
Intervention: Therapeutic alliance (measured by The Human Connection Scale, range: 16-64)
Number of subjects: 672

Group type: EXPERIMENTAL
Intervention: Therapeutic alliance
Number of subjects: 672

Group type: EXPERIMENTAL
Intervention: Quality of life (measured by Functional Assessment of Cancer Therapy-Palliative Care, range: 0-184)
Number of subjects: 672
Study: 32557921

Group type: EXPERIMENTAL
Intervention: MCA pulsatility index < 5th percentile
Number of subjects: 856

Group type: EXPERIMENTAL
Intervention: UCR Z-score above gestational-age-specific thresholds (1.5 at 32-33 weeks and 1.0 at 34-36 weeks)
Number of subjects: 856

Group type: COMPARATOR
Intervention: Normal outcome
Number of subjects: 856
Study: 36348417

Group type: EXPERIMENTAL
Intervention: Endovascular embolization of the middle meningeal artery (eMMA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional neurosurgical treatment (control)
Number of subjects: 0
Study: 33496811

Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (no inhaled fluticasone propionate)
Number of subjects: 14
Study: 32660260

Group type: EXPERIMENTAL
Intervention: EP test-guided group (n=57) with adjunctive posterior wall isolation (PWI) performed in those with positive results (PWI subgroup; n=24)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: EP test-guided group (n=57)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control group (n=54)
Number of subjects: 111
Study: 35303880

Group type: EXPERIMENTAL
Intervention: BMS-986020 (LPA1 antagonist)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 33125587

Group type: EXPERIMENTAL
Intervention: Treatment Ambassador Program (TAP), an 8-session, peer-based, behavioral intervention
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Treatment Ambassador Program (TAP)
Number of subjects: 84
Study: 32950113

Group type: EXPERIMENTAL
Intervention: 4-hour workshop on teamwork
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study: 35800232

Group type: EXPERIMENTAL
Intervention: Cable-pin system
Number of subjects: 50
Study: 34590586

Group type: EXPERIMENTAL
Intervention: E‐learning group (n=12)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Traditional teaching methods group (n=9)
Number of subjects: 21
Study: 33962365

Group type: EXPERIMENTAL
Intervention: BF-FO (morning FO intake: DHA 1010 mg; EPA 240 mg; evening placebo: DHA 40 mg; EPA 15 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: DN-FO (evening FO intake: DHA 1010 mg; EPA 240 mg; morning placebo: DHA 40 mg; EPA 15 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: BF-FO
Number of subjects: 20

Group type: COMPARATOR
Intervention: BF-FO and DN-FO
Number of subjects: 20
Study: 32289716

Group type: EXPERIMENTAL
Intervention: Accelerated rTMS protocol (conventional 10-Hz rTMS or intermittent theta burst stimulation)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Standard rTMS protocol
Number of subjects: 189
Study: 36208057

Group type: EXPERIMENTAL
Intervention: MNZ + blue light
Number of subjects: 251

Group type: COMPARATOR
Intervention: MNZ
Number of subjects: 251

Group type: COMPARATOR
Intervention: blue light
Number of subjects: 251
Study: 33674933

Group type: EXPERIMENTAL
Intervention: Cooling at 18°C (Group 1)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Cooling at 22°C (Group 2)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 156
Study: 32305223

Group type: EXPERIMENTAL
Intervention: Previous CABG
Number of subjects: 2253

Group type: COMPARATOR
Intervention: No previous CABG
Number of subjects: 2253
Study: 36300550

Group type: EXPERIMENTAL
Intervention: Fluconazole (100 mg tablet) from Glenmark
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Fluconazole (100 mg tablet) from Citron
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Fluconazole (100 mg tablet) from Harris
Number of subjects: 6

Group type: COMPARATOR
Intervention: Fasted treatment
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Fed treatment
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 6
Study: 35010402

Group type: EXPERIMENTAL
Intervention: Simple Resistance Intervention (SRI) program, home-based, consisting of 30 min of resistance exercise three times/week for 12 weeks, health education on sarcopenia.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual exercise (Control group).
Number of subjects: 80
Study: 35302681

Group type: EXPERIMENTAL
Intervention: Quarterly fremanezumab
Number of subjects: 838

Group type: EXPERIMENTAL
Intervention: Monthly fremanezumab
Number of subjects: 838

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 838

Group type: EXPERIMENTAL
Intervention: Both dosing regimens of fremanezumab
Number of subjects: 838
Study: 33003972

Group type: EXPERIMENTAL
Intervention: ICD
Number of subjects: 266

Group type: COMPARATOR
Intervention: Control
Number of subjects: 266
Study: 33214390

Group type: EXPERIMENTAL
Intervention: VIBEDE (novel iterative denoising and image enhancement technique)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: VIBEDE
Number of subjects: 50
Study: 36115677

Group type: EXPERIMENTAL
Intervention: Diluted vasopressin injection (20 units mixed with 100 mL normal saline)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Diluted vasopressin injection (20 units mixed with 200 mL normal saline)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Diluted vasopressin injection (20 units mixed with 400 mL normal saline)
Number of subjects: 39
Study: 33957292

Group type: EXPERIMENTAL
Intervention: tDCS combined with CT
Number of subjects: 67

Group type: COMPARATOR
Intervention: sham tDCS combined with CT
Number of subjects: 67

Group type: COMPARATOR
Intervention: CT alone
Number of subjects: 67
Study: 32367124

Group type: EXPERIMENTAL
Intervention: High-intensity exercise 3 times per week for 3 months
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study: 33595593

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 4744

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4744
Study: 32890862

Group type: EXPERIMENTAL
Intervention: Transdiagnostic Sleep and Circadian Intervention (TranS‐C)
Number of subjects: 22
Study: 33740346

Group type: EXPERIMENTAL
Intervention: High frequency percutaneous electrical nerve stimulation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low frequency percutaneous electrical nerve stimulation
Number of subjects: 40
Study: 616401456

Group type: EXPERIMENTAL
Intervention: Intravenous drip of 1200 mg of glutathione once a day for eight weeks
Number of subjects: 104

Group type: COMPARATOR
Intervention: Intravenous drip of 0.4 g of inosine injection with 250 ml of 5% glucose once a day for eight weeks (Control)
Number of subjects: 104
Study: 35651860

Group type: EXPERIMENTAL
Intervention: Tiny Habits for Gratitude (n = 50)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Tiny Habits Control (n = 52)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Inactive Control (n = 52)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Tiny Habits for Gratitude (n = 50) at 1 month
Number of subjects: 154

Group type: COMPARATOR
Intervention: Inactive Control (n = 52) at 1 month
Number of subjects: 154
Study: 34633422

Group type: EXPERIMENTAL
Intervention: Whole-fat dairy
Number of subjects: 49

Group type: COMPARATOR
Intervention: Reduced-fat dairy
Number of subjects: 49
Study: 32222912

Group type: EXPERIMENTAL
Intervention: BC 007 (15 mg, 50 mg, 150 mg)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: BC 007 (150 mg)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: BC 007 (50 mg, 150 mg)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: BC 007 (300 mg, 450 mg, 750 mg, 1350 mg, 1900 mg)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 35104787

Group type: EXPERIMENTAL
Intervention: Virtual Reality Mental Training (VRMT)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Conventional Mental Training (CMT)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 57
Study: 34473029

Group type: EXPERIMENTAL
Intervention: Surgical treatment with complete revascularization
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conservative medical treatment with incomplete revascularization
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Complete revascularization
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Recanalization of culprit vessels
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 29
Study: 35734514

Group type: EXPERIMENTAL
Intervention: Thiamine mononitrate 500 mg for 90 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo for 90 days
Number of subjects: 24
Study: 33058401

Group type: EXPERIMENTAL
Intervention: Pamphlet on paediatric eye health
Number of subjects: 518

Group type: COMPARATOR
Intervention: Pamphlet on infant play (control)
Number of subjects: 518
Study: 36430081

Group type: EXPERIMENTAL
Intervention: IMB‐based health education intervention
Number of subjects: 119

Group type: COMPARATOR
Intervention: Standard care session (control group)
Number of subjects: 119
Study: 34262398

Group type: EXPERIMENTAL
Intervention: Transdermal testosterone gel (TTG) for 4 weeks
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Transdermal testosterone gel (TTG) for 6 weeks
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control group (no TTG)
Number of subjects: 122
Study: 33143538

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36213928

Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS
Number of subjects: 47

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 47
Study: 35234730

Group type: EXPERIMENTAL
Intervention: Unreamed intramedullary nailing
Number of subjects: 55

Group type: COMPARATOR
Intervention: External fixation
Number of subjects: 55
Study: 33465457

Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 3139

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3139
Study: 35328874

Group type: EXPERIMENTAL
Intervention: Task-oriented training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Table-top activity training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Task-oriented training and Table-top activity training
Number of subjects: 20
Study: 32769596

Group type: EXPERIMENTAL
Intervention: Electromagnetic-focused extracorporeal shockwave treatment (F-ESWT) with energy flux density of 0.20 mJ/mm
Number of subjects: 103

Group type: COMPARATOR
Intervention: Sham F-ESWT with energy flux density of 0.01 mJ/mm
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: F-ESWT group
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: F-ESWT in association with a specific exercise program
Number of subjects: 103
Study: 35745278

Group type: EXPERIMENTAL
Intervention: Two whole eggs with 70 g of spinach/day (EGG)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Egg substitute with spinach (SUB)
Number of subjects: 24
Study: 34187492

Group type: EXPERIMENTAL
Intervention: Flexible diet (FLEX)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Rigid diet (RIGID)
Number of subjects: 23
Study: 35978353

Group type: EXPERIMENTAL
Intervention: WeChat-based cognitive behavioral therapy intervention
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 76
Study: 33209182

Group type: EXPERIMENTAL
Intervention: Community-Based Health Insurance (CBHI)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Proposed solutions for CBHI
Number of subjects: 75
Study: 34775775

Group type: EXPERIMENTAL
Intervention: ACP discussions with trained nurses
Number of subjects: 230
Study: 32968936

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 162

Group type: COMPARATOR
Intervention: Routine symptomatic treatment (Control)
Number of subjects: 162
Study: 35861952

Group type: EXPERIMENTAL
Intervention: VR‐BiT (Virtual Reality Body Image Training)
Number of subjects: 17
Study: 33453498

Group type: EXPERIMENTAL
Intervention: Single-session transcranial Direct Current Stimulation (tDCS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: SZ patients
Number of subjects: 24
Study: 32858333

Group type: EXPERIMENTAL
Intervention: Insufficient Sleep (6.5 hours in bed)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sufficient Sleep (9.5 hours in bed)
Number of subjects: 30
Study: 36309128

Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR)
Number of subjects: 456

Group type: COMPARATOR
Intervention: Surgical aortic valve replacement (SAVR)
Number of subjects: 456
Study: 34617959

Group type: COMPARATOR
Intervention: Standard-dose heparins
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Therapeutic-dose LMWH (enoxaparin, 1 mg/kg subcutaneous, twice daily)
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Therapeutic-dose heparins
Number of subjects: 253

Group type: COMPARATOR
Intervention: Standard-dose heparins (non-ICU)
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Therapeutic-dose heparins (non-ICU)
Number of subjects: 253

Group type: COMPARATOR
Intervention: Standard-dose heparins (ICU)
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Therapeutic-dose heparins (ICU)
Number of subjects: 253
Study: 32616433

Group type: EXPERIMENTAL
Intervention: Aflibercept (AFL) with FOLFIRI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ramucirumab (RAM) with FOLFIRI
Number of subjects: 0

Group type: COMPARATOR
Intervention: FOLFIRI alone
Number of subjects: 0
Study: 33241725

Group type: EXPERIMENTAL
Intervention: Tapentadol prolonged release (PR)
Number of subjects: 0
Study: 32492084

Group type: EXPERIMENTAL
Intervention: Convalescent plasma therapy in addition to standard treatment (n=52)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Standard treatment alone (control) (n=51)
Number of subjects: 103
Study: 35784436

Group type: EXPERIMENTAL
Intervention: mCCT (high amount ∼USD 15 per fully immunized child)
Number of subjects: 11197

Group type: EXPERIMENTAL
Intervention: mCCT (low amount ∼USD 5 per fully immunized child)
Number of subjects: 11197

Group type: EXPERIMENTAL
Intervention: Certain payment design
Number of subjects: 11197

Group type: EXPERIMENTAL
Intervention: Airtime payment method
Number of subjects: 11197

Group type: COMPARATOR
Intervention: SMS reminder only
Number of subjects: 11197

Group type: EXPERIMENTAL
Intervention: Flat payment schedule
Number of subjects: 11197
Study: 33316165

Group type: EXPERIMENTAL
Intervention: Activity trackers with 5 daily alarms
Number of subjects: 48

Group type: COMPARATOR
Intervention: Activity trackers alone
Number of subjects: 48
Study: 35101885

Group type: COMPARATOR
Intervention: pembrolizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: atezolizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: cemiplimab‐rwlc
Number of subjects: 0
Study: 34865335

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS) for 30 min (8‐12 mA) immediately after surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no TEAS)
Number of subjects: 60
Study: 35355160

Group type: EXPERIMENTAL
Intervention: U-net
Number of subjects: 796

Group type: EXPERIMENTAL
Intervention: Attention U-net
Number of subjects: 796

Group type: EXPERIMENTAL
Intervention: CE-net
Number of subjects: 796

Group type: EXPERIMENTAL
Intervention: U-net with ResNet
Number of subjects: 796

Group type: EXPERIMENTAL
Intervention: Automatic segmentation
Number of subjects: 796
Study: 33017060

Group type: EXPERIMENTAL
Intervention: Reinforced PTFE membranes (Group A)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Titanium meshes plus collagen membranes (Group B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups (A and B)
Number of subjects: 40
Study: 35585556

Group type: EXPERIMENTAL
Intervention: Single-cycle intrathecal therapy with two repeated injections of BM-MSCs (Lenzumestrocel) with a 26-day interval
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Single-cycle intrathecal therapy with two repeated injections of BM-MSCs (Lenzumestrocel) with a 26-day interval + three additional booster injections at 4, 7, and 10 months
Number of subjects: 115
Study: 33689236

Group type: EXPERIMENTAL
Intervention: Continuous infusion (CI) of furosemide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bolus injection (BI) of furosemide
Number of subjects: 0
Study: 32301113

Group type: EXPERIMENTAL
Intervention: 2-hour partograph action line
Number of subjects: 640

Group type: COMPARATOR
Intervention: 4-hour partograph action line
Number of subjects: 640
Study: 36216218

Group type: EXPERIMENTAL
Intervention: Quadriceps tendon autograft (QT-A)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Hamstring tendon autograft (HT-A)
Number of subjects: 90
Study: 34053861

Group type: EXPERIMENTAL
Intervention: Pembrolizumab (200 mg)
Number of subjects: 290

Group type: COMPARATOR
Intervention: Pembrolizumab (200 mg) plus carboplatin (AUC 5) plus pemetrexed (500 mg/m2)
Number of subjects: 290
Study: 32356489

Group type: EXPERIMENTAL
Intervention: Advance care planning discussions before illness
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Factors associated with willingness before illness in Japan
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Factors associated with willingness before illness in Taiwan
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Attitudes towards advance care planning discussions
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Healthcare providers' initiative for discussions
Number of subjects: 700
Study: 36007982

Group type: EXPERIMENTAL
Intervention: Insulin glargine 300 U/mL (Gla-300)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin degludec U100 (iDeg-100)
Number of subjects: 0
Study: 34461080

Group type: EXPERIMENTAL
Intervention: 100 mg sildenafil citrate tablets
Number of subjects: 40
Study: 35969004

Group type: EXPERIMENTAL
Intervention: Clazakizumab
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 34125743

Group type: EXPERIMENTAL
Intervention: Static core exercises
Number of subjects: 30

Group type: COMPARATOR
Intervention: Swiss ball training
Number of subjects: 30
Study: 32517582

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 15 mg daily
Number of subjects: 7213

Group type: COMPARATOR
Intervention: Aspirin 100 mg daily
Number of subjects: 7213
Study: 33048344

Group type: EXPERIMENTAL
Intervention: Dose-dense weekly paclitaxel with 3-weekly carboplatin
Number of subjects: 246

Group type: COMPARATOR
Intervention: Standard 3-weekly chemotherapy
Number of subjects: 246
Study: 32275352

Group type: EXPERIMENTAL
Intervention: Garcinia kola (bitter kola) 100 mg/kg body weight in a 200 ml solution
Number of subjects: 46

Group type: COMPARATOR
Intervention: Water (placebo control)
Number of subjects: 46
Study: 35844452

Group type: EXPERIMENTAL
Intervention: Bisphosphonate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 34498764

Group type: EXPERIMENTAL
Intervention: Filgrastim (FIL)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Pegfilgrastim (PEG)
Number of subjects: 90
Study: 33326335

Group type: EXPERIMENTAL
Intervention: Synchronized intermittent mandatory pressure-controlled ventilation
Number of subjects: 36
Study: 33138927

Group type: EXPERIMENTAL
Intervention: Outpatient motivational enhancement therapy (MET, four sessions)
Number of subjects: 693

Group type: EXPERIMENTAL
Intervention: Outpatient MET plus community reinforcement approach for seniors (MET & CRA-S; up to 12 sessions)
Number of subjects: 693
Study: 34375501

Group type: EXPERIMENTAL
Intervention: Plyometrics exercises
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Balance exercises
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Combination of both exercises
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study: 34813687

Group type: EXPERIMENTAL
Intervention: RISE (1-6 sessions of psychosocial counseling)
Number of subjects: 60

Group type: COMPARATOR
Intervention: ECAU (enhanced care as usual, single session of psychoeducation, safety planning, resources, and referrals)
Number of subjects: 60
Study: 34625482

Group type: EXPERIMENTAL
Intervention: Guide sheath (GS)
Number of subjects: 596

Group type: COMPARATOR
Intervention: Non-guide sheath (non-GS)
Number of subjects: 596
Study: 33432670

Group type: EXPERIMENTAL
Intervention: Family-focused therapy for high-risk youth (FFT-HR)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Enhanced Care (EC)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 40
Study: 35500971

Group type: EXPERIMENTAL
Intervention: Static stretching
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Strengthening exercise in lengthened hamstring position
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control
Number of subjects: 45
Study: 36455146

Group type: EXPERIMENTAL
Intervention: Combined management of weight, blood pressure, and blood lipids
Number of subjects: 380

Group type: COMPARATOR
Intervention: Anti-atherosclerotic treatments (Control)
Number of subjects: 380
Study: 34408252

Group type: EXPERIMENTAL
Intervention: Urea + 5 Mg biochar ha-1 (B5)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Urea + 10 Mg biochar ha-1 (B10)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 5 Mg biochar ha-1 (B5)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 10 Mg biochar ha-1 (B10)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control (no biochar or urea)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Sole urea (150 kg N ha-1)
Number of subjects: 4
Study: 35776235

Group type: EXPERIMENTAL
Intervention: Neuropsychological test performance (Amsterdam Cognition Scan)
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Self-reported cognitive functioning (Cognitive Symptom Checklist‐work)
Number of subjects: 279